Cargando…

Catalytically inactive receptor tyrosine kinase PTK7 activates FGFR1 independent of FGF

Protein tyrosine kinase 7 (PTK7), a catalytically defective receptor protein tyrosine kinase (RPTK), plays an oncogenic role by activating an unidentified TKI-258 (dovitinib)-sensitive RPTK in esophageal squamous cell carcinoma (ESCC) cells. Here, we demonstrate that among TKI-258–sensitive RPTKs, f...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shin, Won-Sik, Lee, Hae Won, Lee, Seung-Taek
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Federation of American Societies for Experimental Biology 2019
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6902674/ https://www.ncbi.nlm.nih.gov/pubmed/31490704 http://dx.doi.org/10.1096/fj.201900932R

Ejemplares similares

PTK7, a Catalytically Inactive Receptor Tyrosine Kinase, Increases Oncogenic Phenotypes in Xenograft Tumors of Esophageal Squamous Cell Carcinoma KYSE-30 Cells
por: Shin, Won-Sik, et al.
Publicado: (2022)

Catalytically defective receptor protein tyrosine kinase PTK7 enhances invasive phenotype by inducing MMP-9 through activation of AP-1 and NF-κB in esophageal squamous cell carcinoma cells
por: Shin, Won-Sik, et al.
Publicado: (2016)

Anti-PTK7 Monoclonal Antibodies Inhibit Angiogenesis by Suppressing PTK7 Function
por: Oh, Si Won, et al.
Publicado: (2022)

Knockdown of PTK7 Reduces the Oncogenic Potential of Breast Cancer Cells by Impeding Receptor Tyrosine Kinase Signaling
por: Shin, Won-Sik, et al.
Publicado: (2023)

Biphasic regulation of tumorigenesis by PTK7 expression level in esophageal squamous cell carcinoma
por: Shin, Won-Sik, et al.
Publicado: (2018)

Identification and targeting of protein tyrosine kinase 7 (PTK7) as an immunotherapy candidate for neuroblastoma
por: Lee, Jasmine Y., et al.
Publicado: (2023)

The catalytically defective receptor protein tyrosine kinase EphA10 promotes tumorigenesis in pancreatic cancer cells
por: Shin, Won‐Sik, et al.
Publicado: (2020)

Anti-PTK7 Monoclonal Antibodies Exhibit Anti-Tumor Activity at the Cellular Level and in Mouse Xenograft Models of Esophageal Squamous Cell Carcinoma
por: Kim, Jae Hoon, et al.
Publicado: (2022)

Protein Tyrosine Kinase 7 (PTK7) Promotes Metastasis in Hepatocellular Carcinoma via SOX9 Regulation and TGF-β Signaling
por: Wong, Tsz Lam Matthew, et al.
Publicado: (2022)

Protein tyrosine kinase, PtkA, is required for Mycobacterium tuberculosis growth in macrophages
por: Wong, Dennis, et al.
Publicado: (2018)

An Alignment-Independent 3D-QSAR Study of FGFR2 Tyrosine Kinase Inhibitors
por: Jafari, Behzad, et al.
Publicado: (2017)

Characterization of Atypical Protein Tyrosine Kinase (PTK) Genes and Their Role in Abiotic Stress Response in Rice
por: Elangovan, Allimuthu, et al.
Publicado: (2020)

Protein Tyrosine Kinase 7 (PTK7) as a Predictor of Lymph Node Metastases and a Novel Prognostic Biomarker in Patients with Prostate Cancer
por: Zhang, Hongtuan, et al.
Publicado: (2014)

Bioinformatics Analysis Identifies Protein Tyrosine Kinase 7 (PTK7) as a Potential Prognostic and Therapeutic Biomarker in Stages I to IV Hepatocellular Carcinoma
por: Zou, Ren-Chao, et al.
Publicado: (2019)

The protein tyrosine kinases EpsB and PtkA differentially affect biofilm formation in Bacillus subtilis
por: Gerwig, Jan, et al.
Publicado: (2014)

Differential Specificity of Endocrine FGF19 and FGF21 to FGFR1 and FGFR4 in Complex with KLB
por: Yang, Chaofeng, et al.
Publicado: (2012)

Effects of FGFR Tyrosine Kinase Inhibition in OLN-93 Oligodendrocytes
por: Rajendran, Ranjithkumar, et al.
Publicado: (2021)

FGF/FGFR signaling in health and disease
por: Xie, Yangli, et al.
Publicado: (2020)

Prognostic value of protein tyrosine kinase 6 (PTK6) for long-term survival of breast cancer patients
por: Aubele, M, et al.
Publicado: (2008)

Expression of protein tyrosine kinase 6 (PTK6) in nonsmall cell lung cancer and their clinical and prognostic significance
por: Zhao, Chao, et al.
Publicado: (2013)

Expression of FGF8, FGF18, and FGFR4 in Gastroesophageal Adenocarcinomas
por: Jomrich, Gerd, et al.
Publicado: (2019)

The inhibition of tyrosine kinase receptor signalling in leiomyosarcoma cells using the small molecule kinase inhibitor PTK787/ZK222584 (Vatalanib(®))
por: GAUMANN, ANDREAS K.A., et al.
Publicado: (2014)

FGFR1 tyrosine kinase domain duplication in pilocytic astrocytoma with anaplasia
por: Ballester, Leomar Y., et al.
Publicado: (2018)

Effects of FGFR2 kinase activation loop dynamics on catalytic activity
por: Karp, Jerome M., et al.
Publicado: (2017)

PTK7 Faces the Wnt in Development and Disease
por: Berger, Hanna, et al.
Publicado: (2017)

A Src-Like Inactive Conformation in the Abl Tyrosine Kinase Domain
por: Levinson, Nicholas M, et al.
Publicado: (2006)

Targeting the FGF/FGFR axis and its co-alteration allies
por: Uehara, Y., et al.
Publicado: (2022)

Catalytically inactive telomerase in oncogenesis
por: Tergaonkar, Vinay
Publicado: (2015)

Long-range replica exchange molecular dynamics guided drug repurposing against tyrosine kinase PtkA of Mycobacterium tuberculosis
por: Nagpal, Priya, et al.
Publicado: (2020)

Circular RNA protein tyrosine kinase 2 (circPTK2) promotes colorectal cancer proliferation, migration, invasion and chemoresistance
por: Jiang, Zhipeng, et al.
Publicado: (2022)

FGF /FGFR Signal Induces Trachea Extension in the Drosophila Visual System
por: Chu, Wei-Chen, et al.
Publicado: (2013)

Escape from HER family tyrosine kinase inhibitor therapy by the kinase inactive HER3
por: Sergina, Natalia V., et al.
Publicado: (2007)

Targeting the Oncogenic FGF-FGFR Axis in Gastric Carcinogenesis
por: Zhang, Jinglin, et al.
Publicado: (2019)

FGF19–FGFR4 Signaling in Hepatocellular Carcinoma
por: Raja, Aroosha, et al.
Publicado: (2019)

Molecular elements in FGF19 and FGF21 defining KLB/FGFR activity and specificity
por: Agrawal, Archita, et al.
Publicado: (2018)

Erlotinib binds both inactive and active conformations of the EGFR tyrosine kinase domain
por: Park, Jin H., et al.
Publicado: (2012)

FGF7–FGFR2 autocrine signaling increases growth and chemoresistance of fusion‐positive rhabdomyosarcomas
por: Milton, Christopher I., et al.
Publicado: (2021)

The impact of FGF19/FGFR4 signaling inhibition in antitumor activity of multi-kinase inhibitors in hepatocellular carcinoma
por: Kanzaki, Hiroaki, et al.
Publicado: (2021)

PTK (protein tyrosine kinase)-6 and HER2 and 4, but not HER1 and 3 predict long-term survival in breast carcinomas
por: Aubele, M, et al.
Publicado: (2007)

The Alternative Splice Variant of Protein Tyrosine Kinase 6 Negatively Regulates Growth and Enhances PTK6-Mediated Inhibition of β-Catenin
por: Brauer, Patrick M., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_5easornsioj3e2aels6hkt7l7c